IN THIS ISSUE

Editor's Memo
John Marcille
Legislation & Regulation
John Carroll
One of the possible issues is 'biosimilars,' agents that would fill the role that generics play in traditional pharmacy coverage
Medication Management
Martin Sipkoff
Health insurers' aggressive stand on members' use of generic drugs can attract new clients, but does it interfere with the physician-patient relationship?
Tomorrow's Medicine
Thomas Morrow, MD
The less common form of hemophilia — acquired hemophilia — can now be treated with recombinant activated factor VII

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report